Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Parkinsons Disease Drugs Market in United States Growth, Trends and Forecasts to -2025 on December 7, 2018 at 2:50 pm
Parkinsons Disease Drugs Market provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets. It offers a quantitative analysis from ... […]
- A gut-brain link for Parkinson’s gets a closer look on December 7, 2018 at 6:25 am
Sources: N. Titova et al/NPJ Parkinsons Disease 2018; R.P. Friedland and M.R. Chapman/PLOS Pathogens 2017 People with Parkinson’s often have digestive issues, such as constipation, long before the dis... […]
- Neurodiagnostic and Monitoring Devices Market Size 2018, Market Benefits, Forthcoming Developments, Business Opportunities and Future Investments on December 6, 2018 at 3:35 am
Parkinsons disease, and ischemic stroke. These devices include equipment such as CT scanner, MRI scanner, PET scanner, and others., , Neurodiagnostic and Monitoring Devices market research report 2018 ... […]
- Funds help exercise group for the disabled get physical in Northampton on December 5, 2018 at 9:12 am
Northamptonshire Community Foundation this year awarded £4,320 to fund a wellness gym at Lodge Farm Community Centre, aimed at people with disabilities including MS, Parkinsons and cancer. The money h... […]
- World War II weapon used in new battle: combatting Parkinsons disease on December 5, 2018 at 4:15 am
Purdue University research shows the antidote can effectively remove acrolein, a neurotoxin produced in the body that is directly correlated with Parkinson’s disease. WEST LAFAYETTE, Ind. – A World Wa... […]
- Billy Connolly Answers Claims That His Parkinson’s “Dulled” His Brain on December 3, 2018 at 5:37 pm
Billy Connolly hasn’t been doing a lot of interviews, so when a story came out via Michael Parkinson saying that his Connolly’s Parkinsons Disease had taken a serious turn for the worse ... […]
- CBD Oil for ADHD? The Facts About This Popular Natural Treatment on November 16, 2018 at 9:15 am
This helps to explain why so many people are exploring its benefits for diseases and disorders ranging from Alzheimer’s and Parkinsons to PTSD and, yes, attention deficit disorder (ADHD or ADD). Thoug... […]
- Parkinsons Disease Education And Support Group on November 6, 2018 at 7:00 pm
Meet other people with Parkinson’s disease and talk about how to cope with changes in your life. Speak to health professionals about how to live well with Parkinson’s disease. Care partners of individ... […]
- The Fantastic Four – Another great visit with Mackay Parkinsons Support Group on October 18, 2018 at 8:26 am
This is the (fantastic) fourth occasion that I have been lucky enough to have been invited to speak with members of the Mackay Parkinsons Support group at the North Mackay Bowls Club. We are all start... […]
via Bing News